SW403人結(jié)腸癌細胞、SW4
- 公司名稱 上海富雨生物科技有限公司
- 品牌
- 型號
- 產(chǎn)地
- 廠商性質(zhì) 生產(chǎn)廠家
- 更新時間 2025/4/24 14:34:52
- 訪問次數(shù) 75
聯(lián)系方式:陳壽彬18956075901 查看聯(lián)系方式
聯(lián)系我們時請說明是化工儀器網(wǎng)上看到的信息,謝謝!
SW403 人結(jié)腸癌細胞
Catalogue No.: C1497
Product Format: a T25 flask
Culture Properties:貼壁
Complete Growth Medium: 89%L15+10%FBS+1%雙抗
Atmosphere: air, 99%
Application: Cells and cancer research
NOTE: FOR RESEARCH USE ONLY.
Components
Item | Specifications |
a T25 flask | 2X106 |
Manual | 1 copy |
1 (PD-1), which greatly enriches the choice of tumor immunotherapy. Related immune checkpoint inhibitors including CTLA4 inhibitors such as ipilimumab and tremelimumab, PD-1/programmed death 1 ligand 1 (PD-L1) inhibitors such as nivolumab, pembrolizumab and atezolizumab have been prepared and applied in the therapy of solid tumors such as melanoma, non-small cell lung cancer, digestive tract tumors and so on, which have get a